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At least  three  different  types of cells  are  needed  for a  humoral  response  to 
most  antigens.  The  bone  marrow-derived  lymphocyte  (B  cell)  produces  the 
humoral  antibody  (1,  2)  and  is  triggered  by  a  cooperating  thymus-derived 
lymphocyte  (T  cell)  to  do  so  (3).  A  phagocytic cell,  the  macrophage  (M4), 
is often needed to "process" or "handle" the antigen (4, 5) for this cooperation. 
The  details  of  these  cell  interactions  are  not  complete  and  several  models 
have  been  proposed  (6-9)  for  them.  We  have  tried  to  interfere  with  some 
aspects  of antigen processing by M~b to see whether  such processed antigen is 
necessary for T  cell priming, B  cell priming, or for both and for the cooperating 
events  between  B  and  T  cells.  To do  this,  we  treated  erythrocytes  with  for- 
maldehyde or glutaraldehyde  and  tested  their  immunogenicity in vivo and in 
vitro. 
Chicken  erythrocytes  (CRBC)  so  treated  show  no  gross  changes  in  anti- 
genicity judged by their agglutination patterns with antibody prepared against 
native  CRBC. Table I  shows that CRBC fixed with formaldehyde (F-CRBC) 
have  the  same  agglutinability  with  anti-CRBC  antibody  as  untreated  ceils, 
while  somewhat  higher  titers  were  usually  found  with  glutaraldehyde-fixed 
CRBC  (G-CRBC),  probably  because  they tend  to clump spontaneously.  But 
untreated  and  fixed  red  cells probably are processed or handled differently by 
M~b.  I Recently it  has  been  shown  that  M~b  readily  phagocytose formalinized 
sheep erythrocytes (SRBC)  (10),  although they do not phagocytose untreated 
SRBC  or  CRBC  (11),  unless  anti-red  cell  antibody  is  present.  When  M4~ 
from animals  immunized  with  red  cells  are incubated  with  the same red  cells 
overnight, they release  in a  soluble form a  material  (4)  which is immunogenic 
in Mishell-Dutton  type cultures (12). 
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t Macrophages  referred  to in  this  paper  are  peritoneal  exudate  cells (PEC)  which  are 
obtained 2-4 days after intraperitoneal injection of peptone broth  (4). 
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Thus  supernatants  obtained  after  incubation  of  a  suspension  of  CRBC, 
together  with  immune  PEC,  could  be  shown  to  effectively stimulate  an  anti- 
CRBC  response  by  cultured  spleen  cells  (Table  II).  Supernatants  from  a 
TABLE I 
Agglutination of CRBC, F-CRBC, and G-CRBC by Anti-CRBC Antiserum 
Agglutination titer on 
CRBC  F-CRBC  G-CRBC 
29  29  21o_211 
Anti-CRBC serum was raised by intraperitoneal injection of 0.2 ml 10% CRBC suspension 
into B6D2F1  (C57BL/6J  X  DBA/2J) mice for 3 wk. F-CRBC were prepared  by adding an 
8%  suspension  of red  cells  in phosphate-buffered  saline  (PBS)  to  an equal volume of 3% 
formaldehyde followed by incubation for 18 hr at 37°C with agitation. The cells were washed 
five times in balanced salt solution (BSS)  (12) and stored for 3 days in fetal calf serum. After 
washing in BSS, they were kept frozen at -20°C. G-CRBC were prepared by mixing 2 ml of 
25% red cells with 25 ml of BSS and adding an equal amount of 0.25% glutaraldehyde for 5 
min  at  20°C.  The  cells were washed  and  treated  as  described for F-CRBC. Agglutination 
titrations  were done,  using  a  0.5%  red  cell suspension  in  PBS  and  microtiter  equipment 
(Microbiological Associates, Inc., Bethesda, Md.). 
TABLE II 
Release of Antigenic Material From Normal Vs. Fixed CRBC by M$ 
Antigen in culture  pfc/10 6 recovered cells on day 5 
--  <0.2 
106 CRBC  2080 
CRBC (supernatant)  290 
F-CRBC (supernatant)  <0.2 
M4~ (supernatant)  114 
CRBC-Mq~  (supernatant)  1280 
F-CRBC-Mq~ (supernatant)  <0.2 
B6D2F1 mice were immunized with 0.2 ml 10% CRBC on day --7. On day --3, they were 
injected intraperitoneally with 1.5 ml of proteose peptone (4) ; 107 PEC were incubated with 
or without 2  X  l0 s CRBC or F-CRBC in 2 ml of tissue culture medium  (4)  for 24 hr. The 
supernatants of these incubations were harvested by centrifugation (10 min at 1000 rpm) and 
0.5-ml aliquots were mixed with 0.5 ml of fresh tissue culture medium and  1.3  X  107 spleen 
cells from B6D2F1 mice primed with 0.2 ml 10%  CRBC  on day  --30. Assays for pfc were 
done on day 5 (14). 
CRBC supernatant  =  supernatant from CRBC incubated without Mq~; F-CRBC super- 
natant  =  supernatant  from  F-CRBC incubated  without  M~b; MS supernatant  =  super- 
natant from MS incubated without red cells; CRBC-M~ supernatant  =  supernatant  from 
CRBC incubated with MqS; F-CRBC-M~ supernatant  =  supernatant  from F-CRBC incu- 
bated with M4~. 
suspension  of  CRBC  alone also stimulated  an  in vitro response,  probably  due 
to  spontaneous  lysis of  cells,  but  the  effect was  much  smaller.  The  same was 
true for the M~b supernatant.  In this  case,  it is possible that  antigen had  been 658  SELECTIVE PRIMING  OF T  CELLS 
carried  over  by  the  PEC  due  to  the  prior  intraperitoneal  immunization  on 
day -- 7. However, there was no release of immunogenic material from F-CRB C 
alone or if admixed with PEC,  indicating that fixed cells cannot be processed 
by M~b to a  soluble immunogenic form. Because the M4) supernatant by itself 
had some activity, it is somewhat surprising that the F-CRBC incubated with 
M~b was completely inactive. We have no explanation for this finding. That the 
F-CRBC  are simply toxic in in vitro cultures is excluded by the  experiments 
referred to below (Table IV). 
Mice  injected  with  F-CRBC  and  G-CRBC  showed  a  very  poor  primary 
response,  if  any,  to  these  antigens  as  compared with  the  response  to  CRBC 
(Table III). But on challenge with CRBC,  7 days after the primary immuniza- 
TABLE  III 
In Vivo Response to CRBC and Fixed CRBC 
Primary response  Secondary response 
pfc/l@ spleen cells on  pfe/lOS spleen  cells on 
Antigen per mouse  day 5  Antigen per mouse  day 11 
19S  19S+ 7S  19S  19S-[-  7S 
1.5  X  10 s CRBC  880  880  1.5 X  10 s CRBC  3168  16,068 
1.5 X  l0 s F-CRBC  118  30  1.5  X  10 s CRBC  4928  23,500 
1.5  X  l0 s G-CRBC  188  106  1.5  X  l0 s CRBC  2726  17,400 
--  139"  114"  --  --  -- 
Groups of  10  B6D2F1  mice were  intravenously injected, respectively, with  1.5  X  l0 s 
CRBC,  F-CRBC, and G-CRBC.  On day 5, direct and direct plus indirect pfc were assayed 
in the spleens. 6 days after primary injection, all three groups were challenged with 1.5 X  10 8 
CRBC  and  the secondary response  was  assayed on  day 11.  Figures given  indicate mean 
values of groups  of five mice. Indirect plaques were  developed  by incubation with an ap- 
propriate dilution of a rabbit anti-mouse IgG serum 1 hr before adding guinea pig complement. 
* Background values represent upper limits of pooled determinations for 10 animals. 
tion, all three groups gave very high 19S and 7S responses. It was striking that 
the  animals primed with F-CRBC  always showed somewhat higher responses 
than the controls injected with CRBC. This demonstrated that though the fixed 
red cells were not able to evoke a  humoral response, they were in fact at least 
as  potent  as  normal  cells  in  priming  the  animals  for  a  secondary  response. 
To find out whether  either plaque-forming cell (pfc)  precursors or thymus- 
derived helper cells had been primed, mice were injected with increasing doses 
of CRBC and F-CRBC. 5 days later, the spleens of these animals were cultured 
with trinitrophenyl (TNP)-CRBC  (13), and the response to CRBC- and TNP- 
antigen  was  assayed separately. Fig.  1  shows  that  a  dose of  10  4 CRBC  gave 
optimal  priming  for  both  the  CRBC  and  TNP  response;  lower  and  higher 
doses of antigen were somewhat less effective. This result which also holds for 
printing  with  SRBC  in  mice  (reference  14  and  our  unpublished  results)  is 
quite different from that found with F-CRBC. Low doses of F-CRBC showed 
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As  the  anti-TNP  response was  even somewhat  better  than  the  anti-CRBC 
response, it can be concluded that the thymus-derived helper cells and not the 
pfc precursors had  been primed.  Otherwise,  only a  stimulation  of  the  anti- 
CRBC response would have been observed. 
If this interpretation is correct, injection of thymus cells  and fixed red cells 
into  lethally irradiated  animals  should  result  in  priming  of  thymus-derived 
helper  cells  (15).  Table  IV  shows  that  T  spleen  cells  sensitized  to CRBC, 
F-CRBC,  and  G-CRBC  stimulate  both  the  anti-CRBC  and  anti-TNP  re- 
sponses  equally well.  But,  as  found in  vivo, neither F-CRBC  nor G-CRBC 
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FIG. 1. Groups of three 9  B6D2F1 mice were injected intravenously with 103-107 CRBC 
or F-CRBC. 5 days later spleens were cultured with 106 TNP-CRBC (13) in triplicate dishes 
for 5  days.  Direct pfc were assayed on  CRBC  and TNP-burro erythrocytes (BRBC)  and 
are expressed as pfc per 106 recovered cells. •  0, anti-CRBC pfc; •  .....  l,  anti-TNP pfc. 
stimulated  a  pfc response. To exclude that  the fixed red cells are toxic in in 
vitro cultures, they were mixed with TNP-CRBC. As can be seen from Table 
IV, a perfectly normal response to both CRBC and TNP antigens developed. 
In summary, we have shown that fixed CRBC retain their immunogenicity 
toward T  cells (Fig.  1, Table IV), but fail to induce the humoral response as 
measured in terms of numbers of pfc (Tables III and IV). Essentially similar 
results  (not  described here)  have been obtained with fixed SRBC.  Given in 
low doses, fixed cells seem to be slightly less effective than untreated red cells, 
but high doses show very good T  cell priming (Fig. 1). Me release soluble im- 
munogenic material from normal red cells  (Table II),  but fail to do so from 
fixed red  cells.  Thus we show that  chemical  modification of the immunogen 
prevents Me from releasing soluble immunogen, and also interferes in an asym- 
metrical way with B cell and T  cell priming. While this may imply that antigen 
processing is a prerequisite for B cell priming, it does not exclude the participa- 
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These  findings  might  provide  a  powerful  tool  for  sensitizing  T  cells  and 
raising  cell-mediated  immune  responses  to  allogeneic  and  tumor-specific  cell 
surface  antigens.  Preliminary  experiments  using  such  systems  have,  in  fact, 
shown  that  fixed  allogeneic  and  syngeneic  tumor  cells  are  able  to  raise  cell- 
TABLE  IV 
Priming  of T  Spleen  Cells by CRBC,  F-CRBC,  and  G-CRBC 
Sensitized T  spleen cells per culture  Antigen  per culture 
pfc/106  recovered cells on 
CRBC  TNP-BRBC 
m 
m 
m 
--  4  3 
106 TNP-CRBC  6  30 
i06 F-CRBC  <1  -- 
106 G-CRBC  2  -- 
5  X  106 T  cells (CRBC)  --  1  1 
5  X  106  "  "  106 TNP-CRBC  415  1310 
5  X  106  "  "  106 F-CRBC  <1  -- 
5  X  106  ....  106 G-CRBC  1  -- 
5  X  106 T  cells (CRBC) 
5 X  106  "  " 
106 TNP-CRBC  +  106 F-CRBC  554  1790 
106 TNP-CRBC  +  106 G-CRBC  800  1980 
5 X  106 T  cells (F-CRBC)  --  1  23 
5 X  106  ....  106 TNP-CRBC  375  1180 
5 )<  10 G  ....  106 F-CRBC  <1  4 
5 X  106 T  cells (G-CRBC)  --  5  4 
5  X  106  ....  106 TNP-CRBC  310  950 
5  X  106  "  "  106 G-CRBC  <1  -- 
l0 s  thymus cells and  1.4  X  l0 s  CRBC,  F-CRBC,  and  G-CRBC  suspensions were  in- 
jected into lethally irradiated (1000 R,  6°Co) B6D2F1 mice (14).  8 days later T  spleens were 
harvested and 5  X  106 T  spleen cells were mixed with 10 7 11 spleen cells (spleen cells of thy- 
mectomized, lethally irradiated, and bone marrow-protected animals) per culture and antigen 
as indicated. Pfc were assayed on day 5. 
T  cells (CRBC)  =  T  spleen  cells sensitized with CRBC; T  cells (F-CRBC)  =  T  spleen 
cells sensitized with F-CRBC; T  cells  (G-CRBC)  =  T  spleen ceils sensitized with  G-CRBC. 
mediated  immunity.  Experiments  are  in progress  to  further  exploit  this tech- 
nique. 
We thank Dr.  E.  S.  Lennox for  encouraging and stimulating discussions and R.  Austin 
for excellent help. 
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